TheraSyn Bio and Rubix LS have announced a groundbreaking joint venture, Project Panacea, to develop a topical breast cancer therapy. Combining synthetic biology and AI-driven patient insights, the treatment aims to improve precision, reduce systemic toxicity, and enhance accessibility....
↧
